Novartis AG (NVS) Fundamentals

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
SHARE INFORMATION
Market CapUS$ 165,979,244,232
Shares Outstanding2,182,788,588
Float2,182,788,588
Percent Float100.0%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 3.20
Latest Fiscal RevenueUS$ 48,689,482,801
Latest Fiscal EPSUS$ 10.63
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)US$ 4.67
Dividend (5 Years)US$ 3.51
Ex Dividend Date2022-03-08
Dividend RateUS$ 3.33
Dividend Yield4.37%
Payment CashCash
HOLDERS
Institutions1,590
Institutional Holdings Date2022-09-30
Institutional Bought Previous 3 Months9,850,880
Institutional Holdings Percent15.7%
Institutional Sold Previous 3 Months23,346,554
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned-
TRADING INFO
52 Week HighUS$ 94.26
52 Week LowUS$ 74.09
52 Week High ChangeUS$ -3.18
21 Day Moving AverageUS$ 78.5324
21 Day Extended Moving AverageUS$ 78.1933
50 Day Moving AverageUS$ 81.7868
50 Day Extended Moving AverageUS$ 80.6502
200 Day Moving AverageUS$ 84.6918
200 Day Extended Moving AverageUS$ 84.4255
10 Day Average Volume3,239,203
20 Day Average Volume2,653,246
30 Day Average Volume2,841,188
50 Day Average Volume2,365,048
Alpha-0.001066
Beta0.4994
Standard Deviation0.056229
R20.214474
7 Day Price ChangeUS$ -0.53
7 Day Percent Change-0.69%
21 Day Price ChangeUS$ -4.70
21 Day Percent Change-5.82%
30 Day Price ChangeUS$ -3.73
30 Day Percent Change-4.68%
Month to Date Price ChangeUS$ 0.03
Month to Date Percent Change0.04%
Quarter to Date Price ChangeUS$ 0.03
Quarter to Date Percent Change0.04%
180 Day Price ChangeUS$ -14.61
180 Day Percent Change-16.12%
200 Day Price ChangeUS$ -10.75
200 Day Percent Change-12.39%
Year to Date Price ChangeUS$ -7.95
Year to Date Percent Change-9.46%

Novartis AG (NVS) Key Ratios

PROFITABILITY
EBIT Margin48.7%
EBITDA Margin60.4%
Pre-Tax Profit Margin41.5%
Profit Margin Count48.89%
Gross Margin69.9%
Profit Margin TOT48.89%
INCOME STATEMENTS
RevenueUS$ 36,607,606,649
Revenue Per ShareUS$ 16.771
Revenue (3 Years)US$ 0.00
Revenue (5 Years)US$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book372.10
Total Debt To Equity0.50
Int Coverage31.70
Current Ratio1.40
Leverage Ratio1.90
Quick Ratio1.00
Long Term Debt To Capital0.27
VALUATION MEASURES
PE Ratio7.40
Enterprise ValueUS$ 181,588,276,010
Price to Sales4.534
Price to Free Cash8.80
PE High Last 5 Years28.00
Price To Book2.80
Price To Cash Flow12.80
PE Low Last 5 Years13.70
Price to Tangible Book372.10
MANAGEMENT EFFECTIVENESS
Receivables Turnover4.50
Invoice Turnover2.40
Assets Turnover0.30
Return Assets19.77
Return on Equity41.53
Return on Capital25.81

Novartis AG (NVS) Profile

PROFILE INFO
Issue TypeCS
SEC TypeDR
AuditorPricewaterhouseCoopers AG
CEOVasant Narasimhan
Emplyoees104323
Last AuditUE
CIK0001114448
IndustryDrug Manufacturers
SectorHealthcare
NAICS-
CONTACT INFO
AddressLichtstrasse 35
Basel, 4056
Websitehttps://www.novartis.com
Facsimile+41 613247826
Telephone+41 613241111
Emailinvestor.relations@novartis.com
Su Consulta Reciente
NYSE
NVS
Novartis
Regístrese ahora para ver estas acciones en su Monitor streaming ADVFN.

Usted puede agregar y ver hasta 110 símbolos de sus acciones favoritas al mismo tiempo y completamente gratis.

Inicie sesión en ADVFN
Regístrase ahora
Cotizaciones PLUS están en tiempo real. Cotizaciones NYSE y AMEX están con retraso de por lo menos 20 minutos.
El resto de las cotizaciones están con retraso de por lo menos 15 minutos al menos que se indique lo contrario.

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

P: V:mx D:20221007 22:16:55